ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 35 filers reported holding ONCOCYTE CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,000 | -80.0% | 500 | -80.0% | 0.00% | – |
Q3 2019 | $5,000 | -73.7% | 2,500 | -66.7% | 0.00% | – |
Q2 2019 | $19,000 | +850.0% | 7,500 | +1400.0% | 0.00% | – |
Q1 2019 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
Q4 2017 | $2,000 | – | 500 | +2281.0% | 0.00% | – |
Q3 2016 | $0 | – | 21 | 0.0% | 0.00% | – |
Q2 2016 | $0 | – | 21 | 0.0% | 0.00% | – |
Q1 2016 | $0 | – | 21 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 3,056,680 | $15,895,000 | 2.92% |
IHT Wealth Management, LLC | 200 | $386,000 | 0.19% |
Family Management Corp | 22,570 | $117,000 | 0.08% |
Artal Group S.A. | 150,000 | $780,000 | 0.01% |
Destination Wealth Management | 29,656 | $154,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 145,000 | $754,000 | 0.01% |
Advisor Group, Inc. | 102 | $1,000 | 0.00% |
FIFTH THIRD BANCORP | 210 | $1,000 | 0.00% |
HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 2,233 | $12,000 | 0.00% |